The COVID-19 pandemic has established provide chain gaps in crucial drug items, particularly those necessary for the most crucial sufferers in intensive care units across the nation.
DARPA (Protection Advanced Investigate Project Company) has selected Continuity Pharma, a Purdue College-affiliated firm, to establish ongoing producing know-how. The firm was chosen for a $1.5 million grant.
DARPA has established a aggressive evaluate process, awarding grant funding to providers presenting state-of-the-art production systems.
Continuity Pharma’s mission is to utilize novel steady production abilities to reshore generic drug solutions to the U.S., with distinct aim on medications in shorter offer.
We are thrilled to be picked by DARPA to additional our development initiatives. We are just one move closer to guaranteeing the availability of critical medicines to individuals in will need. It is an interesting time for Continuity Pharma.”
David Thompson, Purdue professor of organic chemistry and co-founder and chief scientific officer at Continuity
Grant specifics include development funding over the up coming 24 months, with further funding for commercialization in the subsequent 12 months. Focus locations involve capabilities for many API production in the Built-in Continuous Production Method, with shown efficiencies for fast changeover and production efficiencies.
Continuity Pharma leaders are performing with Purdue Research Basis officials to secure additional lab space in Purdue Research Park in West Lafayette.